Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Operating Leases: 2019-2024

Historic Operating Leases for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $284,000.

  • Benitec Biopharma's Operating Leases rose 73.16% to $613,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $613,000, marking a year-over-year increase of 73.16%. This contributed to the annual value of $284,000 for FY2024, which is 49.19% down from last year.
  • Latest data reveals that Benitec Biopharma reported Operating Leases of $284,000 as of FY2024, which was down 49.19% from $559,000 recorded in FY2023.
  • Over the past 5 years, Benitec Biopharma's Operating Leases peaked at $811,000 during FY2022, and registered a low of $213,000 during FY2021.
  • For the 3-year period, Benitec Biopharma's Operating Leases averaged around $551,333, with its median value being $559,000 (2023).
  • As far as peak fluctuations go, Benitec Biopharma's Operating Leases surged by 280.75% in 2022, and later crashed by 49.19% in 2024.
  • Over the past 5 years, Benitec Biopharma's Operating Leases (Yearly) stood at $405,000 in 2020, then tumbled by 47.41% to $213,000 in 2021, then surged by 280.75% to $811,000 in 2022, then tumbled by 31.07% to $559,000 in 2023, then slumped by 49.19% to $284,000 in 2024.